Materials & Resources » Chemicals | Aceto Corp.

Aceto Corp. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
499,690.00
510,179.00
546,951.00
558,524.00
638,318.00
Cost of Goods Sold (COGS) incl. D&A
401,419.00
396,276.00
416,307.00
417,052.00
509,946.00
Gross Income
98,271.00
113,903.00
130,644.00
141,472.00
128,372.00
SG&A Expense
60,611.00
66,387.00
75,199.00
83,444.00
88,448.00
EBIT
37,660.00
47,516.00
53,827.00
-
39,924.00
Unusual Expense
3,404.00
3,284.00
1,803.00
10.00
9,885.00
Non Operating Income/Expense
281.00
281.00
146.00
27.00
428.00
Interest Expense
2,122.00
2,100.00
3,954.00
6,510.00
15,770.00
Pretax Income
34,550.00
44,674.00
53,865.00
53,854.00
17,361.00
Income Tax
12,222.00
15,674.00
20,382.00
19,088.00
5,985.00
Consolidated Net Income
22,328.00
29,000.00
33,483.00
34,766.00
11,376.00
Net Income
22,328.00
29,000.00
33,483.00
34,766.00
11,376.00
Net Income After Extraordinaries
22,328.00
29,000.00
33,483.00
34,766.00
11,376.00
Net Income Available to Common
22,328.00
29,000.00
33,483.00
34,766.00
11,376.00
EPS (Basic)
0.81
1.02
1.14
1.18
0.35
Basic Shares Outstanding
27,050.00
28,001.00
28,731.00
29,110.00
32,283.00
EPS (Diluted)
0.81
1.02
1.14
1.18
0.35
Diluted Shares Outstanding
27,450.00
28,563.00
29,247.00
29,581.00
32,632.00
EBITDA
44,604.00
55,608.00
65,676.00
72,039.00
64,581.00
Other Operating Expense
-
-
1,618.00
-
-
Non-Operating Interest Income
345.00
237.00
282.00
313.00
264.00
Equity in Affiliates (Pretax)
1,790.00
2,024.00
1,761.00
2,060.00
2,336.00

About Aceto

View Profile
Address
4 Tri Harbor Court
Port Washington New York 11050
United States
Employees -
Website http://www.aceto.com
Updated 09/14/2018
Aceto Corp. engages in the development, marketing, sales, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products.